DiaMedica Therapeutics (DMAC) Payables (2017 - 2026)
DiaMedica Therapeutics (DMAC) reported Payables of $2.81 million for Q2 2026, up 123.0% from $1.26 million a year earlier but down 14.6% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, DiaMedica Therapeutics posted Payables of $1.48 million, up 56.9% from FY2024.
- Payables has increased for four consecutive years, with a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- By year, Payables came in at $940,000 in FY2024 (+1.5%), $926,000 in FY2023 (+26.2%), $734,000 in FY2022 (+44.2%) and $509,000 in FY2021 (-53.7%).
- Five-year quarterly Payables spans a low of $433,000 in Q1 2022 and a high of $3.29 million in Q1 2026.
- Year over year, Payables has now increased in each of the last eight quarters, with growth averaging 72.0% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q1 2023 (growth of 311.1%); the low point was Q1 2024 (a decline of 59.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.29 million (Q1 2026), $1.48 million (Q4 2025) and $1.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | DiaMedica Therapeutics | 521.46 Mn | 311.42 Mn | - | 2.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.81 Mn |
| Mar 31, 2026 | 3.29 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 940,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 759,000.00 |
| Mar 31, 2024 | 716,000.00 |
| Dec 31, 2023 | 926,000.00 |
| Sep 30, 2023 | 863,000.00 |
| Jun 30, 2023 | 856,000.00 |
| Mar 31, 2023 | 1.78 Mn |
| Dec 31, 2022 | 734,000.00 |
| Sep 30, 2022 | 864,000.00 |
| Jun 30, 2022 | 624,000.00 |
| Mar 31, 2022 | 433,000.00 |
| Dec 31, 2021 | 509,000.00 |
| Sep 30, 2021 | 699,000.00 |
API Access
DiaMedica Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();